Literature DB >> 20111021

Metabolic adaptation follows contractile dysfunction in the heart of obese Zucker rats fed a high-fat "Western" diet.

Mathias Burgmaier1, Shiraj Sen, Femi Philip, Christopher R Wilson, Charles C Miller, Martin E Young, Heinrich Taegtmeyer.   

Abstract

The normal heart responds to changes in its metabolic milieu by changing relative oxidation rates of energy-providing substrates. We hypothesized that this flexibility is lost when genetically obese rats are fed a high-caloric, high-fat "Western" diet (WD). Male Zucker obese (ZO) and Zucker lean (ZL) rats were fed either control or WD composed of 10 kcal% and 45 kcal% fat, respectively, for 7 or 28 days. Cardiac triglycerides and mRNA transcript levels were measured in situ. Substrate oxidation rates and cardiac power were measured ex vivo. Hearts from ZO rats fed WD for 7 days showed decreased cardiac power and increased cardiac triglyceride content, but no change in oleate oxidation rates or mRNA transcript levels of pyruvate dehydrogenase kinase-4 (PDK-4), uncoupling protein-3 (UCP-3), and mitochondrial (MTE-1) and cytosolic thioesterase-1(CTE-1). When fed WD for 28 days, ZO rats showed no further decrease in cardiac power and no further increase in intramyocardial triglyceride levels compared to ZO rats fed the same diet for 7 days only, but did show significantly increased oleate oxidation rates and transcript levels of CTE-1, MTE-1, PDK-4, and UCP-3. In contrast, hearts from ZL rats fed WD showed increased rates of oleate oxidation and increased transcript levels of the fatty acid responsive genes investigated, and no further deterioration of contractile function. We conclude that exposing a genetic model of obesity to the nutrient stress of WD results in an early reversible loss of metabolic flexibility of the heart that is accompanied by contractile dysfunction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20111021      PMCID: PMC3623948          DOI: 10.1038/oby.2009.500

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  26 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

Review 2.  Linking gene expression to function: metabolic flexibility in the normal and diseased heart.

Authors:  Heinrich Taegtmeyer; Leonard Golfman; Saumya Sharma; Peter Razeghi; Melissa van Arsdall
Journal:  Ann N Y Acad Sci       Date:  2004-05       Impact factor: 5.691

Review 3.  AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome.

Authors:  Neil Ruderman; Marc Prentki
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

4.  Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr).

Authors:  S C Chua; D W White; X S Wu-Peng; S M Liu; N Okada; E E Kershaw; W K Chung; L Power-Kehoe; M Chua; L A Tartaglia; R L Leibel
Journal:  Diabetes       Date:  1996-08       Impact factor: 9.461

5.  Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy.

Authors:  C Depre; G L Shipley; W Chen; Q Han; T Doenst; M L Moore; S Stepkowski; P J Davies; H Taegtmeyer
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

Review 6.  Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart.

Authors:  Brian N Finck; Daniel P Kelly
Journal:  J Mol Cell Cardiol       Date:  2002-10       Impact factor: 5.000

7.  Leptin receptor missense mutation in the fatty Zucker rat.

Authors:  M S Phillips; Q Liu; H A Hammond; V Dugan; P J Hey; C J Caskey; J F Hess
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

8.  Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha.

Authors:  J M Brandt; F Djouadi; D P Kelly
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

9.  Utilization of energy-providing substrates in the isolated working rat heart.

Authors:  H Taegtmeyer; R Hems; H A Krebs
Journal:  Biochem J       Date:  1980-03-15       Impact factor: 3.857

10.  Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator-activated receptor-alpha-regulated gene in cardiac and skeletal muscle.

Authors:  Melissa A Stavinoha; Joseph W RaySpellicy; M Faadiel Essop; Christophe Graveleau; E Dale Abel; Mary L Hart-Sailors; Harry J Mersmann; Molly S Bray; Martin E Young
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-03       Impact factor: 4.310

View more
  17 in total

Review 1.  Metabolic stress in the myocardium: adaptations of gene expression.

Authors:  Peter A Crawford; Jean E Schaffer
Journal:  J Mol Cell Cardiol       Date:  2012-06-21       Impact factor: 5.000

Review 2.  Nutritional models of foetal programming and nutrigenomic and epigenomic dysregulations of fatty acid metabolism in the liver and heart.

Authors:  Jean-Louis Guéant; Rania Elakoum; Olivier Ziegler; David Coelho; Eva Feigerlova; Jean-Luc Daval; Rosa-Maria Guéant-Rodriguez
Journal:  Pflugers Arch       Date:  2013-09-03       Impact factor: 3.657

3.  Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats.

Authors:  Annayya R Aroor; James R Sowers; Shawn B Bender; Ravi Nistala; Mona Garro; Irina Mugerfeld; Melvin R Hayden; Megan S Johnson; Muhammad Salam; Adam Whaley-Connell; Vincent G Demarco
Journal:  Endocrinology       Date:  2013-05-07       Impact factor: 4.736

Review 4.  Fatty heart, cardiac damage, and inflammation.

Authors:  Maria A Guzzardi; Patricia Iozzo
Journal:  Rev Diabet Stud       Date:  2011-11-10

Review 5.  Caloric excess or restriction mediated modulation of metabolic enzyme acetylation-proposed effects on cardiac growth and function.

Authors:  Michael N Sack
Journal:  Biochim Biophys Acta       Date:  2011-02-03

6.  Multiphasic triacylglycerol dynamics in the intact heart during acute in vivo overexpression of CD36.

Authors:  Andrew N Carley; Jian Bi; Xuerong Wang; Natasha H Banke; Jason R B Dyck; J Michael O'Donnell; E Douglas Lewandowski
Journal:  J Lipid Res       Date:  2012-10-25       Impact factor: 5.922

Review 7.  Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival.

Authors:  Cecilia C Low Wang; Jane E B Reusch
Journal:  Am J Cardiol       Date:  2012-11-06       Impact factor: 2.778

8.  Obesity and Cardiac Function - The Role of Caloric Excess and its Reversal.

Authors:  Michael N Sack
Journal:  Drug Discov Today Dis Mech       Date:  2013-06-01

9.  Impaired coronary metabolic dilation in the metabolic syndrome is linked to mitochondrial dysfunction and mitochondrial DNA damage.

Authors:  Giacinta Guarini; Takahiko Kiyooka; Vahagn Ohanyan; Yuh Fen Pung; Mario Marzilli; Yeong Renn Chen; Chwen Lih Chen; Patrick T Kang; James P Hardwick; Christopher L Kolz; Liya Yin; Glenn L Wilson; Inna Shokolenko; James G Dobson; Richard Fenton; William M Chilian
Journal:  Basic Res Cardiol       Date:  2016-04-04       Impact factor: 17.165

Review 10.  Lost in translation: miRNAs and mRNAs in ischemic preconditioning and ischemia/reperfusion injury.

Authors:  Roberta A Gottlieb; Somayeh Pourpirali
Journal:  J Mol Cell Cardiol       Date:  2015-11-12       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.